Controlling tumor growth target of cancer trialAugust 18, 2023 Improving outcomes for dogs afflicted with a particularly aggressive and fatal type of cancer is the goal of a clinical trial currently underway. A newly funded study will evaluate the potential of a cancer drug to control tumor growth for dogs with histiocytic sarcoma. The multi-center clinical trial, which is being conducted at Michigan State University (MSU), University of Florida, University of Wisconsin, and Virginia Tech, will be funded by the Bernese Mountain Dog Club of America (BMDCA) through Morris Animal Foundation's Donor-Inspired Study program. Histiocytic sarcoma was first described in Bernese mountain dogs in the late 1970s, but has since been noted in many other breeds, Morris Animal Foundation reports. "Histiocytic sarcoma is a devastating disease, and traditional chemotherapeutic drugs have shown limited success in improving treatment outcomes, especially with the disseminated form of the disease," says the study's principal investigator, Vilma Yuzbasiyan-Gurkan, PhD, a professor of microbiology, molecular genetics, and small animal clinical sciences at MSU. "Based on our studies of the molecular pathways driving tumor growth, we now have an opportunity to use a targeted approach in …
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
UW-Stout to host conference on animal health nutraceuticalsJune 10, 2019The University of Wisconsin (UW)-Stout is hosting a world conference on the use of nutraceuticals in companion animal health care. Sponsored by Vets Plus, the International Conference on Animal Health Nutraceuticals–2019 (ICAHN 2019) takes place from July 17 to 19. "Veterinarians already use probiotics to address digestive ailments and omega-3 fatty acids to improve issues with the skin, coat, and joints," says Vets Plus founder and chief executive office, Raj Lall. "And nutraceuticals are widely used in joint health programs and to address the needs of senior pets. But the number of compounds in current use is small compared to the number we know to have therapeutic benefits. This conference is intended to increase both the profile and practitioner knowledge about this branch of veterinary science." Discussions will feature experts in academia, veterinary practitioners, and internationally published nutritional scientists. Speakers and topics include: An overview of nutraceuticals in animal health and disease (presented by Ramesh Gupta, DVM, MVSc, PhD); Therapeutic uses of cannabinoids in companion animals (presented by Gary Richter, MS, DVM, CVC, CVA); and Future direction and trends in nutraceutical research (presented by W. Thomas Shier, PhD) "Nutraceuticals are being used in virtually every veterinary practice and their …
Avian flu strain spreads to 45 catsDecember 16, 2016A rare avian influenza strain, H7N2, has infected domestic cats for the first time, the University of Wisconsin Veterinary Diagnostic Laboratory reported today.
